Godavari Drugs Ltd. Announces Trading Window Closure
Godavari Drugs Ltd. has announced the closure of its trading window for designated persons and their immediate relatives, effective April 1, 2026. This action is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company’s Code of Conduct.The trading window will remain closed until 48 hours after the audited financial results for the quarter and financial year ending March 31, 2026, are declared.
The date for the Board Meeting to consider and approve the audited financial results will be communicated to the Bombay Stock Exchange (BSE) in due course. Godavari Drugs Ltd.’s BSE scrip code is 530317.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.